["{\n\"step_by_step_thinking\": \"The question is about a drug that selectively inhibits phosphate release by the myosin head. This means that the drug will prevent the phosphorylation of the regulatory light chain of smooth muscle myosin. According to the first document, phosphorylation efficiently regulates the actin-activated ATPase activity of myosin filaments and actin movement in an in vitro motility assay. Therefore, if phosphate release is blocked, this would likely affect the power stroke.\",\n\"answer_choice\": \"D\"\n}"]